Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine

Front Pharmacol. 2024 Jul 23:15:1399598. doi: 10.3389/fphar.2024.1399598. eCollection 2024.

Abstract

The liver, a complex parenchymal organ, possesses a distinctive microcirculatory system crucial for its physiological functions. An intricate interplay exists between hepatic microcirculatory disturbance and the manifestation of pathological features in diverse liver diseases. This review updates the main characteristics of hepatic microcirculatory disturbance, including hepatic sinusoidal capillarization, narrowing of sinusoidal space, portal hypertension, and pathological angiogenesis, as well as their formation mechanisms. It also summarized the detection methods for hepatic microcirculation. Simultaneously, we have also reviewed the characteristics of microcirculatory disturbance in diverse liver diseases such as acute liver failure, hepatic ischemia-reperfusion injury, viral hepatitis, non-alcoholic fatty liver disease, hepatic fibrosis, hepatic cirrhosis, and hepatocellular carcinoma. Finally, this review also summarizes the advancement in hepatic microcirculation attributed to traditional Chinese medicine (TCM) and its active metabolites, providing novel insights into the application of TCM in treating liver diseases.

Keywords: active metabolite; hepatic microcirculatory disturbance; liver disease; pathogenesis; traditional Chinese medicine.

Publication types

  • Review

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (T2341004, 82321004, 82174054, 82125038), Guangdong Basic and Applied Basic Research Foundation (2021B1515120023, 2023B1515040016, 2020A1515110596), Guangzhou Basic and Applied Basic Research Foundation (2024A04J4093), Guangdong-Hong Kong-Macao Universities Joint Laboratory for the Internationalization of Traditional Chinese Medicine (2023LSYS002), and Guangzhou Key Laboratory of Traditional Chinese Medicine & Disease Susceptibility (2024A03J090), the GDUPS (2019), Innovation Team Project of Guangdong Provincial Department of Education (2020KCXTD003), Science and Technology Development Fund of Macau (0055/2019/AMJ).